X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs PLETHICO PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE PLETHICO PHARMA CADILA HEALTHCARE/
PLETHICO PHARMA
 
P/E (TTM) x 17.7 -1.1 - View Chart
P/BV x 4.0 0.0 23,694.5% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 CADILA HEALTHCARE   PLETHICO PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
PLETHICO PHARMA
Mar-14
CADILA HEALTHCARE/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs558395 141.3%   
Low Rs36231 1,155.0%   
Sales per share (Unadj.) Rs116.3604.4 19.2%  
Earnings per share (Unadj.) Rs17.932.5 55.0%  
Cash flow per share (Unadj.) Rs23.151.3 45.1%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.4473.6 18.0%  
Shares outstanding (eoy) m1,023.7434.08 3,003.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.00.4 1,121.3%   
Avg P/E ratio x25.76.6 392.2%  
P/CF ratio (eoy) x19.94.2 478.7%  
Price / Book Value ratio x5.40.5 1,196.1%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6647,262 6,480.8%   
No. of employees `00011.8NA-   
Total wages/salary Rs m18,5451,596 1,162.0%   
Avg. sales/employee Rs Th10,072.7NM-  
Avg. wages/employee Rs Th1,569.1NM-  
Avg. net profit/employee Rs Th1,547.7NM-  
INCOME DATA
Net Sales Rs m119,04920,598 578.0%  
Other income Rs m1,132386 293.0%   
Total revenues Rs m120,18120,984 572.7%   
Gross profit Rs m28,4752,818 1,010.6%  
Depreciation Rs m5,388642 838.9%   
Interest Rs m9111,593 57.2%   
Profit before tax Rs m23,308969 2,406.6%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644-138 -4,078.6%   
Profit after tax Rs m18,2921,107 1,652.6%  
Gross profit margin %23.913.7 174.9%  
Effective tax rate %24.2-14.3 -169.5%   
Net profit margin %15.45.4 285.9%  
BALANCE SHEET DATA
Current assets Rs m82,00518,877 434.4%   
Current liabilities Rs m60,72011,896 510.4%   
Net working cap to sales %17.933.9 52.8%  
Current ratio x1.41.6 85.1%  
Inventory Days Days7336 203.5%  
Debtors Days Days98198 49.7%  
Net fixed assets Rs m83,7039,861 848.9%   
Share capital Rs m1,024341 300.6%   
"Free" reserves Rs m86,42112,331 700.9%   
Net worth Rs m87,44516,139 541.8%   
Long term debt Rs m25,5514,706 543.0%   
Total assets Rs m180,65333,146 545.0%  
Interest coverage x26.61.6 1,653.4%   
Debt to equity ratio x0.30.3 100.2%  
Sales to assets ratio x0.70.6 106.0%   
Return on assets %10.68.1 130.5%  
Return on equity %20.96.9 305.0%  
Return on capital %22.012.3 178.9%  
Exports to sales %021.4 0.0%   
Imports to sales %015.2 0.0%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs mNA3,136 0.0%   
Fx inflow Rs m42,6834,402 969.5%   
Fx outflow Rs m11,2423,184 353.1%   
Net fx Rs m31,4411,219 2,580.3%   
CASH FLOW
From Operations Rs m9,1932,437 377.2%  
From Investments Rs m-9,737-6,265 155.4%  
From Financial Activity Rs m5152,490 20.7%  
Net Cashflow Rs m-29-1,337 2.2%  

Share Holding

Indian Promoters % 74.8 82.7 90.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.3 193.0%  
FIIs % 5.9 5.5 107.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 7.5 146.7%  
Shareholders   44,069 10,665 413.2%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   PANACEA BIOTECH  DIVIS LABORATORIES  UNICHEM LAB  NATCO PHARMA  AJANTA PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 18, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS